Adcetris Plus Chemo Now First-line Treatment of Adults with sALCL in Europe

The European Commission (EC) has approved Adcetris (brentuximab vedotin) when used alongside chemotherapy as a first treatment for adults with systemic anaplastic large cell lymphoma (sALCL), a type of peripheral T-cell lymphoma (PTCL). The decision to extend Adcetris’ current approval came after the Committee for Medicinal Products for Human Use (CHMP), a branch of the European Medicines Agency (EMA), recommended it for this indication in late March. Adcetris can now be given to treatment naive people…

You must be logged in to read/download the full post.